Pharmaceuticals | Free Full-Text | The Inhibition of Stat5 by a Peptide Aptamer Ligand Specific for the DNA Binding Domain Prevents Target Gene Transactivation and the Growth of Breast and Prostate Tumor Cells | Notes

Next Article in Journal

Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action

Next Article in Special Issue

Structural and Affinity Analyses of G-Quadruplex DNA Aptamers for Camptothecin Derivatives

Previous Article in Journal

Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer

Previous Article in Special Issue

A Review of Therapeutic Aptamer Conjugates with Emphasis on New Approaches

This article is

freely available
re-usable

Pharmaceuticals 2013, 6(8), 960-987; doi:10.3390/ph6080960

Notes on Article Versions

Note	Date
Article Published	20 August 2013 13:21 CEST
article pdf uploaded.	20 August 2013 13:22 CEST
article word file uploaded.	20 August 2013 13:22 CEST
article files uploaded.	20 August 2013 13:22 CEST
article files uploaded.	20 August 2013 13:22 CEST
article files uploaded.	20 August 2013 13:22 CEST
article files uploaded.	20 August 2013 13:22 CEST
article files uploaded.	20 August 2013 13:22 CEST
article files uploaded.	20 August 2013 13:22 CEST
article files uploaded.	20 August 2013 13:22 CEST
article files uploaded.	20 August 2013 13:22 CEST

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert